Trichloroethylene is a probable risk factor for Parkinson’s disease and parkinsonism, a study here found. The finding came from a study of 31 workers at an industrial plant, including three workers with Parkinson’s disease exposed to high levels of trichloroethylene, and from animal experiments, Don M. Gash, Ph.D., of the University of Kentucky, and colleagues …
The U.S. Food and Drug Administration (FDA) sent letters warning seven pharmacy operations that the claims they make about the safety and effectiveness of their so-called “bio-identical hormone replacement therapy,” or “BHRT” products are unsupported by medical evidence, and are considered false and misleading by the agency. FDA is concerned that unfounded claims like these …
Drug Topics Daily News A law was supposed to go into effect in Maine on Jan. 1, prohibiting the use of physician prescribing information for marketing purposes. But a judge has issued a preliminary injunction barring the law from being implemented on the grounds that it is unconstitutional. Learn More: Drug Topics Daily News
The article below does not deal directly with the pharmaceutical industry, it addresses its close cousin, the chemical industry, and a common product, plastic. Endocrine disrupting chemicals was one of the topics I studied and researched in school. It is nice to see that more people are learning about this potential danger. For more information …
Lawyers for hundreds of people who sued Merck & Co. over its withdrawn painkiller Vioxx are challenging a key provision of a proposed $4.85 billion settlement that requires lawyers to advise all or none of their clients to accept the deal.Plaintiffs lawyers who negotiated the settlement said Friday they expect the challenge will be withdrawn, …
The pharmaceutical industry spends almost twice as much on the marketing and promotion of drugs than on research and development, according to a new analysis in this week’s PLoS Medicine. In their analysis of data from two market research companies, IMS and CAM, Marc-André Gagnon and Joel Lexchin (York University, Toronto, Canada) found that US …
FDA informed healthcare professionals of findings from two additional clinical studies, Preoperative Epirubicin Paclitaxel Aranesp Study (PREPARE), and the National Cancer Institute Gynecologic Oncology Group (COG-19), showing an increase in mortality and shorter time to tumor progression in patients with cancer receiving an Erythropoiesis-Stimulating Agent (ESA). Both the PREPARE study in breast cancer and the …
Cardinal Health notified its customers of a voluntary recall for all Alaris Pump modules, model 8100 (formerly known as Medley Pump module), shipped prior to September 27, 2007. The recall covers Alaris Pump modules that were distributed to 46 States, the District of Columbia, Canada, Guam, Puerto Rico and Saudi Arabia. The pump module was …
Stating that they are cooperating fully with the investigating authorities, both the companies denied any misconduct on their part in the program. Denying any role of its employees in the scam, GlaxoSmithKline (GSK) said: “GSK does not believe that its employees or its agents in Iraq knowingly engaged in wrongdoing regarding the oil-for-food program.” Learn …
Big pharma is at it again. This time they lobbied the government of NJ to require a flu shot vaccine for all preschoolers thereby creating a new market for their poorly understood product. The simple fact is that not much is understood about the immune system and requiring preschoolers to take a flu shot exposes …